Posts tagged as: STL Marketing Group back to homepage

STL Marketing Group Attains Current Status on OTC Markets STL Marketing Group Attains Current Status on OTC Markets(0)

STL Marketing Group, Inc. (Pinksheets: STLK) said Tuesday that it has begun the process of filing disclosures and supplementary information to the OTC Markets and received a Current Status Opinion Letter from its counsel.  As a result of the steps to become a fully-transparent public company, OTC Markets has removed the skull and crossbones and “Caveat Emptor” label on Read More

Stay Informed

Receive the OTCS Newsletter *


* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

© 2011 Viper Enterprises, LLC. All rights reserved.